AU2001269121A1 - Substituted amidoalkyl-uracils as parp inhibitors - Google Patents
Substituted amidoalkyl-uracils as parp inhibitorsInfo
- Publication number
- AU2001269121A1 AU2001269121A1 AU2001269121A AU6912101A AU2001269121A1 AU 2001269121 A1 AU2001269121 A1 AU 2001269121A1 AU 2001269121 A AU2001269121 A AU 2001269121A AU 6912101 A AU6912101 A AU 6912101A AU 2001269121 A1 AU2001269121 A1 AU 2001269121A1
- Authority
- AU
- Australia
- Prior art keywords
- uracils
- parp inhibitors
- substituted amidoalkyl
- amidoalkyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10034801A DE10034801A1 (en) | 2000-07-18 | 2000-07-18 | Substituted amidoalkyl uracils and their use |
DE10034801 | 2000-07-18 | ||
PCT/EP2001/007670 WO2002006247A1 (en) | 2000-07-18 | 2001-07-05 | Substituted amidoalkyl-uracils as parp inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001269121A1 true AU2001269121A1 (en) | 2002-01-30 |
Family
ID=7649257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001269121A Abandoned AU2001269121A1 (en) | 2000-07-18 | 2001-07-05 | Substituted amidoalkyl-uracils as parp inhibitors |
Country Status (6)
Country | Link |
---|---|
US (1) | US6649618B2 (en) |
EP (1) | EP1303497A1 (en) |
AU (1) | AU2001269121A1 (en) |
CA (1) | CA2416036A1 (en) |
DE (1) | DE10034801A1 (en) |
WO (1) | WO2002006247A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10201240A1 (en) * | 2002-01-15 | 2003-07-24 | Bayer Ag | New 1-substituted fused bicyclic uracil derivatives, are poly-(ADP-ribose) synthase inhibitors useful for treating e.g. ischemia, reperfusion damage, cardiovascular diseases, arthritis, asthma and neurodegenerative diseases |
US7009052B2 (en) * | 2003-03-20 | 2006-03-07 | Warner Lambert Company Llc | Sulfonamide derivatives |
US20100210700A1 (en) | 2007-05-08 | 2010-08-19 | Schering Corporation | Methods of treatment using intravenous formulations comprising temozolomide |
WO2013064083A1 (en) * | 2011-11-01 | 2013-05-10 | Impact Therapeutics, Inc. | 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof |
EP3332645A1 (en) | 2016-12-12 | 2018-06-13 | Bayer Cropscience AG | Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1959705A1 (en) | 1969-11-28 | 1971-06-03 | Bayer Ag | 1-subst uracil derivs |
DE2126148A1 (en) | 1971-05-26 | 1972-12-07 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Prepn of uracil derivs - useful as plant - protection agents and their inters |
DE2142317A1 (en) | 1971-08-24 | 1973-03-01 | Bayer Ag | Hypnotic uracil derivs - which do not have narcotic props |
JP2860689B2 (en) * | 1990-03-14 | 1999-02-24 | 第一製薬株式会社 | Pyrimidine derivatives |
JP3264579B2 (en) | 1994-03-18 | 2002-03-11 | 扶桑薬品工業株式会社 | Differentiation of Chlamydia trachomatis serotypes |
GB9702701D0 (en) * | 1997-02-01 | 1997-04-02 | Univ Newcastle Ventures Ltd | Quinazolinone compounds |
AU2004200A (en) | 1999-01-14 | 2000-08-01 | Meiji Seika Kaisha Ltd. | Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives |
-
2000
- 2000-07-18 DE DE10034801A patent/DE10034801A1/en not_active Withdrawn
-
2001
- 2001-07-05 CA CA002416036A patent/CA2416036A1/en not_active Abandoned
- 2001-07-05 AU AU2001269121A patent/AU2001269121A1/en not_active Abandoned
- 2001-07-05 EP EP01947443A patent/EP1303497A1/en not_active Ceased
- 2001-07-05 WO PCT/EP2001/007670 patent/WO2002006247A1/en not_active Application Discontinuation
- 2001-07-16 US US09/906,296 patent/US6649618B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2416036A1 (en) | 2002-01-24 |
US6649618B2 (en) | 2003-11-18 |
WO2002006247A1 (en) | 2002-01-24 |
EP1303497A1 (en) | 2003-04-23 |
WO2002006247A8 (en) | 2002-02-21 |
DE10034801A1 (en) | 2002-01-31 |
US20030022905A1 (en) | 2003-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001274009A1 (en) | Substituted indoles as parp inhibitors | |
AU2001258771A1 (en) | -secretase inhibitors | |
AU2001237041A1 (en) | Kinase inhibitors | |
SI1686119T1 (en) | Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors | |
AU2002219555A1 (en) | VLA-4 Inhibitors | |
AU2001240542A1 (en) | Heterocyclic compounds and their use as parp inhibitors | |
AU2002220241A1 (en) | Parb inhibitors | |
AU2001234088A1 (en) | TNF-alpha inhibitors | |
AU2001293297A1 (en) | Phyisological profiling | |
AU2001266345A1 (en) | Five-membered-ring compound | |
AU4217201A (en) | Tri-aryl-substituted-ethane pde4 inhibitors | |
AU5248800A (en) | Fading inhibitors | |
AU2003277674A1 (en) | Novel parp inhibitors | |
AU2001294557A1 (en) | Thrombin inhibitors | |
AU2002222627A1 (en) | Tak1 inhibitors | |
AU2001265871A1 (en) | Substituted sulfonylaminopyrimidines | |
AU2001230605A1 (en) | Apoptosis inhibitor | |
AU2001244562A1 (en) | Neovascularization inhibitors | |
AU2001254731A1 (en) | Substituted phenyluracils | |
AU2001258255A1 (en) | Substituted benzoylcyclohexenones | |
AU2001289937A1 (en) | Substituted 1-aminobutan-3-ol derivatives | |
AU3235100A (en) | Prothease inhibitors | |
AU2002224550A1 (en) | Corrosion inhibitors | |
AU2001232245A1 (en) | Tnf- alpha inhibitors | |
AU2001255408A1 (en) | Tetrahydro-azepinone derivatives as thrombin inhibitors |